The members of the 2024 40 Under 40 in Cancer class were selected by a panel of judges and include the following:

 

• Anand Patel, MD | UChicago Medicine Comprehensive Cancer Center

• Benjamin Andrick, PharmD, BCOP | Geisinger

• Benito Fernandez, MBA | Onco360

• Berfin Mahmut, PT, DPT, CLT-LANA, OnCS | Mount Sinai Tisch Cancer Center

• Caleb J. Scheckel, DO | Oklahoma Cancer Specialists and Research Institute

• Chirayu G. Patel, MD, MPH | Massachusetts General Hospital, Harvard Medical School

• Eric Gartner, PharmD | Florida Cancer Specialists & Research Institute

• Estefania Labanca, PhD | MD Anderson Cancer Center

• Ethan Stickle

• Fraser Peck, MBChB, MRSC | Immunocore

• Frederick Matthew Howard, MD | UChicago Medicine Comprehensive Cancer Center

• Frederic Ivan L. Ting, MD, MAN, MCM, FPCP, FPSMO, FSASS | Corazon Locsin Montelibano Memorial Regional Hospital

• Harrison Ngue, MD/PhD Student | Harvard Medical School, Massachusetts Institute of Technology

• Jaime Laurel Schneider, MD, PhD | Massachusetts General Hospital, Harvard Medical School

• Jasmine Greene, MSW, LCSW, CT | AdventHealth

• Jason Bergsbaken, PharmD, MBA, BCOP | University of Wisconsin Health

• Jennifer Kistama, ML, MSN, RN, CPHQ | Memorial Sloan Kettering Cancer Center

• Jessica Michaud Davis, PharmD, BCOP, CPP | Atrium Health Levine Cancer Institute

• Jesús Kain, MHA, PMP | Texas Oncology

• Justin Arnall, PharmD, BCOP | Atrium Health Specialty Pharmacy Service

• Kah Poh Loh, MBBCh, BAO, MS | University of Rochester Medical Center

• Kimberlee Rowett, DNP(c), MSN, MBA, RN | Intermountain Healthcare

• Kimberly Nettles, PharmD, RPh | Johnson & Johnson Innovative Medicine

• Lang Wu, PhD | University of Hawaii

• Luis Hernandez, PhD, MPH, MSc | Takeda Oncology

• Mark Liu, MHA | Mount Sinai Health System

• Matthew Saylor, PharmD, BCOP | Merck

• Mehwish Ahmad, RN | AstraZeneca

• Michelle Ting-Lin, MD | Tempus AI

• Mina S. Makary, MD, FSVM, FAHA | The Ohio State University Wexner Medical Center

• Narjust Florez, MD | Dana-Farber Cancer Institute

• Nathan H. Walcker, MBA | Florida Cancer Specialists & Research Institute

• Peter DeMuth, PhD | Elicio Therapeutics

• Robbie Lunt | Biodesix

• Roger Orr, PharmD, BCOP | Florida Cancer Specialists & Research Institute

• Ryan O’Leary | BeiGene USA, Inc.

• Stephanie Miranda | Association for Value-Based Cancer Care

• Tamron Little, MAC | The Mesothelioma Center at Asbestos.com

• Veronika Panagiotou, PhD | National Coalition for Cancer Survivorship

• Waqas Haque, MD, MPH, MPhil | University of Chicago

• Zach Harris, MBA, MPH, FACHE, FACMPE | John Muir Health

 

Congratulations to all of the nominees and awardees!